Navigation Links
Orexigen Therapeutics Announces Webcast of Upcoming Presentation at the Cowen & Co. Annual Health Care Conference
Date:2/28/2013

SAN DIEGO, Feb. 28, 2013 /PRNewswire/ -- Orexigen® Therapeutics, Inc. (Nasdaq: OREX) today announced that management will present a company overview at the Cowen & Co. Annual Health Care Conference in Boston. The presentation is scheduled for Monday, March 4, 2013 at 3:30 p.m. Eastern Time. To listen to the live webcast or a replay of the presentation, please visit the Investor Relations section of the Company's Web site at www.orexigen.com. A replay will be available for 14 days after the event.

About Orexigen® Therapeutics
Orexigen Therapeutics, Inc. is a biopharmaceutical company focused on the treatment of obesity. The Company's lead product candidate is Contrave®, which has completed Phase III clinical trials and for which a New Drug Application has been submitted and reviewed by the FDA. The Company has also reached agreement with the FDA on a Special Protocol Assessment for the Light Study, the Contrave cardiovascular outcomes trial. The Company's other product candidate, Empatic™, has completed Phase II clinical trials. Further information about the Company can be found at www.orexigen.com.Orexigen Contact:

Media Contact:  McDavid Stilwell

Denise PowellVP, Corporate Communications and Business Development

WCG(858) 875-8629

(510) 703-9491


'/>"/>
SOURCE Orexigen Therapeutics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Orexigen Therapeutics to Present at Upcoming Investor Conferences
2. Orexigen Therapeutics To Host Analyst Day Event on December 18, 2012
3. Orexigen Therapeutics Reports Financial Results for the Third Quarter Ended September 30, 2012
4. Orexigen Therapeutics announces continued rapid enrollment into the Light Study; enrollment now expected to close by year end 2012
5. Orexigen Therapeutics Announces Presentations at Upcoming Investor Conferences
6. Orexigen Therapeutics Reports Financial Results for the Second Quarter Ended June 30, 2012
7. Orexigen Therapeutics Schedules August 7, 2012 Webcast Discussion of Financial Results for the Second Quarter Ended June 30, 2012
8. Orexigen Therapeutics Announces the Light Study is Enrolling Faster than Originally Projected
9. Orexigen Therapeutics to Present at the JMP Securities Healthcare Conference
10. Orexigen Therapeutics to Present at the Jefferies 2012 Global Healthcare Conference
11. Unigenes Potent, Anorexigenic Peptide, UGP281, Demonstrates Dramatic Dose Dependent Reductions in Food Intake with Subsequent Significant Body Weight Reduction in Preclinical Studies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/28/2020)... ... 2020 , ... CPAP Store USA, known for its one of a kind ... growing and expanding at a rapid rate. Today, CPAP store USA is excited to ... Dallas, located at 3920 Rosemeade Parkway, Suite 150, Dallas, Texas 75287. , Opening the ...
(Date:6/25/2020)... PLEASANTON, Calif. (PRWEB) , ... June 25, 2020 ... ... (NYSE:TFX) focused on addressing unmet needs in the field of urology, today announced ... a UroLift® Center of Excellence. The designation recognizes that Dr. Pacha has achieved ...
(Date:6/25/2020)... NEW LONDON, CT (PRWEB) , ... June 25, ... ... honored yet again on Connecticut Magazine’s 2020 Top Dentist list within the Periodontics ... their two practice locations in New London, CT and Westerly, RI. Laser gum ...
Breaking Medicine Technology:
(Date:6/28/2020)... MILWAUKEE (PRWEB) , ... June 28, 2020 , ... ... allergy/immunology societies around the world, dedicates World Allergy Week, from June 28 to ... pandemic caused by SARS CoV-2. , COVID-19, short for “coronavirus disease 2019”, is ...
(Date:6/24/2020)... (PRWEB) , ... June 24, 2020 , ... Evolved Naturals, ... launched a new website at http://www.evolvednaturals.com The newly launched website showcases a ... broad-spectrum CBD oils , and a comprehensive line of skincare & topical products ...
(Date:6/24/2020)... ... June 24, 2020 , ... SPH ... that Wexford Physician Hospital Organization (PHO) has successfully deployed SPH’s Population Care™ all-payer ... framework of value-based care. Use of Population Care is benefitting more than 77,000 ...
(Date:6/24/2020)... ... June 24, 2020 , ... Dr. Keith ... with lip ties and tongue ties as well as sleep-disordered breathing. Recently completing ... to care with multispecialty teams including myofunctional therapists and sleep surgeons. , The ...
(Date:6/23/2020)... ... 2020 , ... Rritual , the premium brand in the emerging functional ... the President of North America’s leading mushroom adaptogens company. , Dr. Hart has ... his own family medicine clinic in London, Ontario, Canada where he regularly integrates plant-based ...
Breaking Medicine News(10 mins):